If answers here to Oncolix would only be guesses... then the question is, why is anyone holding shares in this company?
If these basic rules of investing escape understanding, investors might as well book a trip to Vegas, where the odds are better.
In this paricular circumstance, one of many, its a matter of supply/demand.
How's the stock performed since the merger on light volume?
How would you expect the stock to perform with an additional 126,000,000 shs potentially added to the float all at once?
What are the catalysts to mitigate a potential share price disaster with this over hang?
Not knowing these answers = investing blind
News 
Market Data 
Discover 
